Safety update on erythropoiesis-stimulating agents: trials within and outside the accepted indications.
about
Casting doubt on the safety of "off-the-shelf" mesenchymal stem cells for cell therapy.Risk management of biosimilars in oncology: each medicine is a work in progress.Quantitative multimodality imaging in cancer research and therapyManagement of lung cancer-associated anaemia: the Spanish Lung Cancer Anaemia Survey (SLCAS).
P2860
Safety update on erythropoiesis-stimulating agents: trials within and outside the accepted indications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety update on erythropoiesi ...... side the accepted indications.
@en
Safety update on erythropoiesi ...... side the accepted indications.
@nl
type
label
Safety update on erythropoiesi ...... side the accepted indications.
@en
Safety update on erythropoiesi ...... side the accepted indications.
@nl
prefLabel
Safety update on erythropoiesi ...... side the accepted indications.
@en
Safety update on erythropoiesi ...... side the accepted indications.
@nl
P1433
P1476
Safety update on erythropoiesi ...... side the accepted indications.
@en
P2093
Pere Gascón
P356
10.1634/THEONCOLOGIST.13-S3-4
P478
13 Suppl 3
P577
2008-01-01T00:00:00Z